Current and historical daily PE Ratio for TRUMY (
Terumo Corp
) from 2008 to Apr 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Terumo stock (TRUMY) PE ratio as of Apr 28 2024 is 39.25.
More Details
Terumo Corp (TRUMY) PE Ratio (TTM) Chart
Terumo Corp (TRUMY) PE Ratio (TTM) Historical Data
View and export this data going back to 2008. Start your Free Trial
Total 1217
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Terumo PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-28 | 35.5 | 2024-02-23 | 41.0 |
| 2024-04-26 | 35.5 | 2024-02-22 | 40.9 |
| 2024-04-25 | 35.6 | 2024-02-21 | 40.4 |
| 2024-04-24 | 36.6 | 2024-02-20 | 40.1 |
| 2024-04-23 | 36.5 | 2024-02-16 | 38.9 |
| 2024-04-22 | 36.3 | 2024-02-15 | 39.8 |
| 2024-04-19 | 35.2 | 2024-02-14 | 39.0 |
| 2024-04-18 | 35.4 | 2024-02-13 | 38.0 |
| 2024-04-17 | 35.7 | 2024-02-12 | 39.5 |
| 2024-04-16 | 36.4 | 2024-02-09 | 39.4 |
| 2024-04-15 | 35.4 | 2024-02-08 | 38.7 |
| 2024-04-12 | 35.9 | 2024-02-07 | 38.3 |
| 2024-04-11 | 35.8 | 2024-02-06 | 36.1 |
| 2024-04-10 | 36.0 | 2024-02-05 | 36.4 |
| 2024-04-09 | 37.2 | 2024-02-02 | 36.5 |
| 2024-04-08 | 37.8 | 2024-02-01 | 36.7 |
| 2024-04-05 | 37.5 | 2024-01-31 | 36.1 |
| 2024-04-04 | 37.6 | 2024-01-30 | 35.8 |
| 2024-04-03 | 37.4 | 2024-01-29 | 36.1 |
| 2024-04-02 | 38.4 | 2024-01-26 | 35.9 |
| 2024-04-01 | 38.1 | 2024-01-25 | 36.1 |
| 2024-03-28 | 39.4 | 2024-01-24 | 36.2 |
| 2024-03-27 | 40.0 | 2024-01-23 | 37.0 |
| 2024-03-26 | 39.5 | 2024-01-22 | 37.2 |
| 2024-03-25 | 39.0 | 2024-01-19 | 36.8 |
| 2024-03-22 | 39.6 | 2024-01-18 | 36.7 |
| 2024-03-21 | 40.4 | 2024-01-17 | 36.3 |
| 2024-03-20 | 40.6 | 2024-01-16 | 36.9 |
| 2024-03-19 | 40.3 | 2024-01-12 | 37.4 |
| 2024-03-18 | 41.5 | 2024-01-11 | 36.3 |
| 2024-03-15 | 41.0 | 2024-01-10 | 37.1 |
| 2024-03-14 | 41.0 | 2024-01-09 | 35.9 |
| 2024-03-13 | 41.2 | 2024-01-08 | 35.2 |
| 2024-03-12 | 41.6 | 2024-01-05 | 34.4 |
| 2024-03-11 | 41.5 | 2024-01-04 | 34.7 |
| 2024-03-08 | 41.6 | 2024-01-03 | 34.4 |
| 2024-03-07 | 42.1 | 2024-01-02 | 34.8 |
| 2024-03-06 | 42.2 | 2023-12-29 | 34.9 |
| 2024-03-05 | 42.5 | 2023-12-28 | 34.8 |
| 2024-03-04 | 42.4 | 2023-12-27 | 34.5 |
| 2024-03-01 | 42.4 | 2023-12-26 | 34.2 |
| 2024-02-29 | 41.6 | 2023-12-22 | 34.7 |
| 2024-02-28 | 41.5 | 2023-12-21 | 34.0 |
| 2024-02-27 | 42.0 | 2023-12-20 | 34.2 |
| 2024-02-26 | 41.5 | 2023-12-19 | 34.3 |
Terumo Corp (TRUMY) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Terumo Corp
NAICS : 339113
ISIN : US88156J1051
Share Class Description:
TRUMY: ADRDescription
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers